The United Nations Office at Geneva
Multimedia Newsroom
STORYLINE
Injectable HIV medicines deal to provide access to generic lifesaver in developing nations
A landmark agreement has been reached allowing for the production of low-cost, injectable HIV medicines in some 90 developing countries where more the majority of infections occur, UNITAID said on Friday.
Selected manufacturers will be able to develop, manufacture and supply lower-cost generic versions of long-acting Cabotegravir (CAB-LA), in line with a deal reached with pharmaceutical firm ViiV Healthcare (ViiV).
“The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to Cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries,” said UNITAID spokesperson Hervé Verhoosel.
The deal is significant because Cabotegravir injections are only needed once every few months. Increasing its supply at a cost that is affordable to low-income countries could help to overcome the stigma that’s associated with taking daily HIV pills - and the burden of having to remember to take them.
“In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV won’t ask for any royalty on the product and for 10 of those countries, ViiV is asking for a smaller-than-usual royalty,” Mr. Verhoosel explained.
The agreement comes after UNITAID-led discussions began in May this year with ViiV, a subsidiary of pharma giant GlaxoSmithkline. It is only seven months since Cabotegravir LA received regulatory approval.
But the process of selecting the companies that will develop, manufacture and supply generic versions of Cabotegravir will take much longer.
“This product will not be there for everybody, that’s first for people who are there the most at risk,” said Mr. Verhoosel, who noted that the cost of the medicine in the US when it comes onstream there “really soon”, was likely to be around $20,000. “That’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
According to UNITAID, the deal offers the possibility of making the injectable prophylactic medicine available in 90 countries where more than 70 per cent of all new HIV infections occurred in 2020.
Up to three drug manufacturers will be licensed to develop the product on a generic basis to avoid supply and distribution issues. “That’s done in a way that we’re sure (that) one, it’s easy for logistics, two…availability, and three, of course, that it will help to bring the cost of the generic version down”, said Mr. Verhoosel.
ends
STORY: Injectable HIV Prevention Medicines Deal - UNITAID
TRT: 02’05”
SOURCE: UNTV CH
RESTRICTIONS: NONE
LANGUAGE: ENGLISH/NATS
ASPECT RATIO: 16:9
DATELINE: Friday 29 July 2022, GENEVA, SWITZERLAND
SHOTLIST
- Medium shot, UN Geneva flag alley.
- Wide shot, press room with panel of speakers, journalists, TV camera on tripod.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries.”
- Medium shot, lateral, podium speakers.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV (ViiV Healthcare) don’t ask any royalty on the product and for 10 of those countries ViiV is asking for a smaller-than-usual royalty.”
- Wide shot, journalists, TV camera, light panel.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This product will not be there for everybody, that’s first for people who are there the most at risk. That’s a product that’s available in the US, and the price of that product for one year in the US for example is approximately 20,000 US dollars, and that’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
- Medium shot, journalists seated at tables, TV camera.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This licence will actually give the option to three different generic manufacturers to develop the product on a generic base. That means that the price that those companies will have we don’t know yet, but that will not only be one company, that will be three different companies and that’s done in a way that we’re sure one, that it’s easy for logistics, two, that ensuring availability, and three, of course, that it will help to bring the cost of the generic version down.”
- Medium shot, journalists.
- Wide shot, journalists, TV camera and light panel.
- Medium shot, journalist.
- Medium shot, journalists, side shot.
Similar Stories
1
1
1
Edited News | OHCHR , UNOG
The appointment on Thursday of Karla Quintana as head of the Independent Institution on Missing Persons in the Syrian Arab Republic is a key development after nearly a year and a half of work by the UN Human Rights Office supporting the institution’s launch.
1
1
1
Edited News | IOM , UNICEF , UNRWA , WHO
The head of the UN migration agency stressed on Friday that Syria is in no position to take back millions of Syrians following the fall of the Assad regime, while there is an urgent need to “re-evaluate” sanctions impacting the war-ravaged country.
1
1
1
Edited News | IIIM , UNHCR
Syria: ‘Key priority’ is to preserve evidence of crimes – UN investigators
In Syria, new access to evidence of horrific human rights violations means that accountability may be closer than ever – if only proof can be preserved, a top UN investigator said on Tuesday.
1
1
1
Edited News | OSE , ICRC , UNHCR
Syria: UN and partners urge action to preserve evidence of prison atrocities, stabilize country
Since the fall of Bashar al-Assad's regime in Syria five days ago, hundreds of people have rushed to Saydnaya prison, desperate to find loved ones. Disturbing images from the prison and other detention centers have since surfaced, exposing the “unimaginable barbarity Syrians have endured for years,” said Jenifer Fenton, spokesperson for the UN special envoy for Syria, on Friday.
1
1
2
Edited News | UNRWA
Gaza: “Sickening normalisation” of suffering, amid attacks on people and aid convoys
Ongoing military operations by the Israeli Defence Forces (IDF) in Gaza continue to devastate Palestinian children and families, with mounting casualties and a critical lack of humanitarian aid for the desperate population.
“Local media reporting here that last night, 30 people were killed in this area in strikes” said a senior emergency officer with the United Nations agency for Palestinian refugees (UNRWA), Louise Wateridge, speaking to reporters in Geneva from central Gaza.
2
1
2
Press Conferences , Edited News | OHCHR
Rights experts call for end to impunity for Israel’s violations of international law
Four independent human rights experts have jointly called for the international community to sanction Israel’s conduct of hostilities in the Occupied Palestinian Territory as well as in the wider Middle East region - including in Syria, Lebanon and Iran. They also called for the restoration of trust in the international justice system through the abandonment of “extreme interpretations” and “double standards” in the application of the universal norms regulating the conduct of war.
1
1
1
Edited News | OCHA , UNHCR
Syria: needs continue to grow amid highly uncertain situation, say aid teams
The historic power shift in Syria and the still volatile situation two days after the fall of Bashar al-Assad’s regime have increased humanitarian needs in a country where nearly 17 million people, including millions of internally displaced, already depended on humanitarian aid before the recent events, UN aid teams said on Tuesday.
2
1
3
Edited News , Press Conferences | OSES
Barely 48 hours since opposition forces including Hayat Tahrir al-Sham (HTS) swept into Damascus and forced out President Bashar al-Assad, the top UN negotiator tasked with helping Syrians’ create a peaceful and democratic future insisted that nothing could be taken for granted.
1
1
1
Edited News | OHCHR , UNOG
UN High Commissioner for Human Rights Chief Volker Türk on Monday called on States to do all in their power to end senseless conflicts and suffering.
1
1
1
Edited News | WHO
No evacuation order given before Kamal Adwan Hospital strike, says WHO
One of the last partially functional health centres in northern Gaza was reportedly hit again overnight into Friday by several strikes, leaving four health workers among the casualties and the dead, according to the UN World Health Organization (WHO).
2
1
2
Edited News , Press Conferences | OCHA
More than 280,000 people have been uprooted in northwest Syria in a matter of days following the sudden and massive offensive into Government-controlled areas led by Hayat Tahrir al-Sham (HTS), which is sanctioned by the Security Council as a terrorist group.
1
1
1
Edited News | OHCHR , UNOG
UN Human Rights Chief Volker Türk has called on the Georgian authorities to respect and protect the rights to freedoms of expression and peaceful assembly following several nights of protests that were marred by violence, and dispersed using disproportionate, and in some cases unnecessary, force by the police in the capital, Tbilisi.